Tsuji Takahiro, Casula Anna, Tomlinson Laurie, Nitsch Dorothea, Hole Barnaby
Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
UK Renal Registry, UK Kidney Association, Bristol, UK.
Clin Kidney J. 2025 Apr 18;18(5):sfaf105. doi: 10.1093/ckj/sfaf105. eCollection 2025 May.
Why more males than females start kidney replacement therapy (KRT) is incompletely understood. Acute kidney injury (AKI) is a possible factor underlying sex differences in chronic kidney disease (CKD) progression, but previous studies regarding this have been inconclusive. We investigated sex differences in the association between AKI and CKD progression in UK nephrology care.
This cohort study uses UK Renal Registry data. Adults with CKD stages 4/5 in 14 nephrology centres in England were followed from January 2018 to December 2021. We compared their baseline characteristics by sex and calculated cause specific hazard ratio (HR) for outcomes: time to AKI stage 2/3 (AKI2/3), initiation of chronic KRT and death by all causes.
A total of 15 547 patients were included. Fewer females (43.8%) were seen in renal centres than males (56.2%). During follow-up, 3909 (25.1%) AKI2/3 episodes, 3510 (22.6%) KRT initiations, and 7293 (46.9%) deaths were observed. Males were more likely than females to experience each outcome: AKI2/3 [adjusted HR 1.39, 95% confidence interval (CI) 1.31-1.49], KRT initiation (adjusted HR 1.51, 95% CI 1.39-1.65) and death (adjusted HR 1.11, 95% CI 1.05-1.16). Adjustment for AKI2/3 did not change the association between being male and the higher risk of KRT initiation.
Being male was associated with a higher risk of AKI2/3, KRT initiation and death. Fewer females appeared in nephrology care data than expected from population CKD prevalence. However, no evidence was found to support the hypothesis that AKI2/3 explains the higher KRT initiation rates seen amongst males.
为何开始肾脏替代治疗(KRT)的男性多于女性,目前尚未完全明确。急性肾损伤(AKI)可能是慢性肾脏病(CKD)进展中性别差异的潜在因素,但此前关于此的研究尚无定论。我们调查了英国肾脏病护理中AKI与CKD进展之间关联的性别差异。
这项队列研究使用了英国肾脏注册数据。对2018年1月至2021年12月期间英格兰14个肾脏病中心的CKD 4/5期成年患者进行随访。我们按性别比较了他们的基线特征,并计算了各结局的病因特异性风险比(HR):达到AKI 2/3期(AKI2/3)的时间、开始慢性KRT以及各种原因导致的死亡。
共纳入15547例患者。在肾脏中心就诊的女性(43.8%)少于男性(56.2%)。随访期间,观察到3909例(25.1%)AKI2/3发作、3510例(22.6%)开始KRT以及7293例(46.9%)死亡。男性比女性更易出现每种结局:AKI2/3[调整后HR 1.39,95%置信区间(CI)1.31 - 1.49]、开始KRT(调整后HR 1.51,95%CI 1.39 - 1.65)和死亡(调整后HR 1.11,95%CI 1.05 - 1.16)。对AKI2/3进行调整并未改变男性与开始KRT的较高风险之间的关联。
男性与AKI2/3、开始KRT和死亡的较高风险相关。肾脏病护理数据中出现的女性少于根据人群CKD患病率预期的数量。然而,未发现证据支持AKI2/3解释男性中较高的KRT起始率这一假设。